Abstract

Aspergillus fumigatus causes several nosocomial pulmonary infections and accounts for high morbidity and mortality rate globally. Among various virulence factors, 1,8-dihydroxynaphthalene-melanin plays an important role in the survival during unfavorable conditions both in vivo and in vitro, masks various molecular patterns associated with A. fumigatus, and protects it from the host immune system. In the present study, we aim to understand the potential of cis-9-hexadecenal as an antimelanogenic compound and its role in modulating other associated virulence factors in A. fumigatus. cis-9-Hexadecenal is a bioactive compound that belongs to C16 mono-unsaturated fatty-aldehyde groups. Minimum effective concentration of cis-9-hexadecenal affecting A. fumigatus melanin biosynthesis was determined using broth microdilution method. The spectrophotometric analysis revealed reduced melanin content (91%) and hydrophobicity (59%) at 0.293 mM of cis-9-hexadecenal. Cell surface organizational changes using electron microscopy showed altered demelanized smooth A. fumigatus conidial surface without any protrusions after cis-9-hexadecenal treatment. The transcript analysis of polyketide synthase (PKS) pksP/alb1 gene was quantified through qRT-PCR which revealed an upregulated expression. Total proteome profiling conducted through LC-MS-MS showed upregulated PKS enzyme but other downstream proteins involved in the 1,8-dihydroxynaphthalene-melanin biosynthesis pathway were absent. The homology modeling of PKS using Expasy’s web server predicted that PKS is stable at varied conditions and is hydrophilic in nature. The Ramachandran plot by PROCHECK confirmed the 3-D structure of PKS to be reliable. Docking analysis using AutoDock-4.2.6 predicted the binding of cis-9-hexadecenal and PKS at Thr-264 and Ser-171 residue via hydrogen bonding at a low binding energy of −4.95 kcal/mol.

Highlights

  • Rapid advancements in medical interventions in the past few years have revolutionized the treatment of life-threatening diseases such as cancer and autoimmune disorders

  • A. fumigatus produces small spores (2−3 μm) that can surpass the human muco-cilliary clearance and it colonizes on the epithelial layer of respiratory airway, causing infections in patients with impaired immunity or those suffering from lung diseases.[2]

  • The results showed that wild type (WT) A. fumigatus produced greenish-gray conidia on Czapek Dox agar (CzA) plates, whereas TC- as well as PQ-treated plates were brown

Read more

Summary

Introduction

Rapid advancements in medical interventions in the past few years have revolutionized the treatment of life-threatening diseases such as cancer and autoimmune disorders. Though, these modern advances are leading to an alarming increase in the number of high risk patients getting susceptible to opportunistic pathogens.[1] Aspergillus fumigatus, ubiquitously present in the environment has emerged as a leading opportunistic fungal pathogen causing more than 90% of invasive fungal infections. It is more challenging to explore a unique target against A. fumigatus as the cellular mechanisms of mammalian cells and A. fumigatus are closely related.[6]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call